口内支架对头颈癌放疗患者的获益:系统综述
结果表明,对于下颌骨上或邻近的下颌骨癌症患者,口内支架可减少口腔黏膜炎、牙关紧闭、口干症(LoE III)并降低健康结构剂量(LoE IV);对于上颌骨上或邻近的上颌骨癌症患者,可减少口腔黏膜炎并降低健康结构剂量(LoE IV)。尽管科学证据有限,但已报告多种获益。
要点
- 下颌骨/邻近区域放疗患者使用口内支架可减少口腔黏膜炎、牙关紧闭和口干症(LoE III)。
- 上颌骨/邻近区域放疗患者使用口内支架可减少口腔黏膜炎(LoE IV)。
- 口内支架可降低健康结构的放疗剂量(LoE IV)。
核心结论
- 尽管科学证据有限,口内支架在头颈癌放疗中与多种获益相关。
主要发现
- 对于下颌骨上或邻近的下颌骨癌症患者,口内支架可减少口腔黏膜炎、牙关紧闭、口干症(LoE III)并降低健康结构剂量(LoE IV)。
- 对于上颌骨上或邻近的上颌骨癌症患者,口内支架可减少口腔黏膜炎并降低健康结构剂量(LoE IV)。
关键数值与推荐
- 研究采用Hadorn和Somerfield标准进行评价,并据此制定指南。
- 下颌骨/邻近区域放疗患者使用口内支架减少口腔黏膜炎、牙关紧闭、口干症的推荐证据等级为LoE III。
- 下颌骨/邻近区域放疗患者使用口内支架降低健康结构剂量的推荐证据等级为LoE IV。
- 上颌骨/邻近区域放疗患者使用口内支架减少口腔黏膜炎和降低健康结构剂量的推荐证据等级为LoE IV。
临床怎么用
- 对于下颌骨上或邻近的下颌骨癌症接受放疗的患者,可考虑使用口内支架以减少口腔黏膜炎、牙关紧闭、口干症并降低健康结构剂量。
- 对于上颌骨上或邻近的上颌骨癌症接受放疗的患者,可考虑使用口内支架以减少口腔黏膜炎并降低健康结构剂量。
局限性
- 科学证据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Intraoral stents aim to reduce the oral complications associated with head and neck cancers radiotherapy. The aim of this study is to determine the benefits associated with these devices. A systematic review was conducted in PubMed, Web of Science, and Scopus databases selecting full articles published in English, Portuguese, or Spanish until June 6, 2020 (PROSPERO registration: CRD42020185065). The studies were evaluated by Hadorn and Somerfield criteria and guidelines were established. Nineteen studies were identified suggesting the use of intraoral stent for radiotherapy for patients with cancer on/near the mandible to reduce oral mucositis, trismus, xerostomia (LoE III), and dose in healthy structures (LoE IV) and for cancer on/near the maxilla to reduce oral mucositis and dose in healthy structures (LoE IV). Despite the limited scientific evidence, several benefits associated with the use of intraoral stent for radiotherapy of the head and neck neoplasia have been reported.
引用
- Alves LDB, Menezes ACS, Pereira DL, et al. Benefits of intraoral stents in patients with head and neck cancer undergoing radiotherapy: Systematic review. Head Neck. 2021. PMID: 33527582. doi:10.1002/hed.26620
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。